Blogs

Stay Informed with COTA

Stay ahead with our blog, your go-to source for the latest in healthcare
technology, policy, and research.

Group 79

4 mins read

How real-world ovarian cancer data will improve outcomes for women

As we recognize Women’s Health Month and approach Mother’s Day, this is a chance to lead differently. We can ask better questions. We can design smarter trials. We can act on data that reflects real life, not just ideal scenarios. One in eight women will develop breast cancer during their lifetime. This year

Stay Informed with COTA

4 mins read

Deloitte’s new Real-World Evidence Survey reveals that life sciences companies are now using real-world data (RWD) and real-world evidence (RWE) throughout the product life cycle—from early discovery through commercialization….

Stay Informed with COTA

4 mins read

In this new blog series from COTA and Deloitte, we will explore the expanding role of real-world data in oncology….

Stay Informed with COTA

3 mins read

Every September, the healthcare, life sciences, and patient advocacy communities mark Blood Cancer Awareness Month, a time to focus on raising awareness about leukemia, lymphoma, myeloma, and other cancers that affect the blood or bone marrow….

Stay Informed with COTA

4 mins read

Innovation is the key to success in the life sciences industry. But with the vast amounts of data being generated by clinical trials and other research, it can be difficult to know where to focus your efforts. COTA’s tailored, fit-for-purpose real-world data (RWD) can help….

Stay Informed with COTA

4 mins read

COTA’s Summer Internship Program provides an opportunity for college students to explore their career interests, learn new skills, and receive mentorship from experts in the field. This year’s interns come from a variety of backgrounds and majors, and are working in a number of different areas within COTA….

Stay Informed with COTA

3 mins read

After working at one of the world’s leading global clinical research organizations, Noel joins us to continue his work advocating for patients and helping to advance therapeutic and diagnostic options for all….